Company Overview and News

2
5 Companies To Watch As Tech Takes Aim At The Finance Industry

7h oilprice
Your license and viewing of our content is subject to the disclosures contained after this article.
WU CSCO

1
XRP Is Not Dead

8h seekingalpha
One thing that I have to remind myself constantly in crypto is to ignore the noise. There are vastly contrasting opinions about the asset in general. Is it the future? Does Bitcoin have any value? Up until this week, are ICOs securities or not? But I don't think any coin in this space has come under as much scrutiny as XRP.
WU

1
Seo Kang-joon talks about being a robot in ‘Are You Human?’

17h entertainment.inquirer.net
Seo Kang-joon talked about playing the role of a robot in the ongoing drama “Are You Human?” during a recent photo shoot with a local magazine, K-Pop Herald reports.
WU

1
Black Pink comes back breaking records

2018-06-18 entertainment.inquirer.net
Their first ever EP “Square Up” landed at number one on iTunes charts in 38 countries around the world, including the Philippines, Indonesia, Malaysia, Singapore and Japan. Lead track “DDU-DU DDU-DU” topped Korea’s most prominent music charts, including Naver Music, Genie Music and Soribada.
WU

1
Interview: Nikolay Storonsky says Revolut will be the Uber of banking | Business | The Sunday Times

2018-06-17 thetimes.co.uk
To save your favourite articles so you can find them later, subscribe to one of our packs.
WU

7
Money laundering - Wikipedia

2018-06-16 en.wikipedia.org
Money laundering is the act of concealing the transformation of profits from illegal activities and corruption into ostensibly "legitimate" assets.[1] The dilemma of illicit activities is accounting for the origin of the proceeds of such activities without raising the suspicion of law enforcement agencies. Accordingly, considerable time and effort is put into devising strategies which enable the safe use of those proceeds without raising unwanted suspicion.
BNPZY WU BNPQY BNPQF

1
DIA’s Jung Chae-yeon confirmed for lead role in upcoming drama

2018-06-13 entertainment.inquirer.net
Jung Chae-yeon of South Korean idol group DIA will star in a new KBS drama, her agency announced.
WU

1
SNSD’s Taeyeon returns with new EP

2018-06-13 entertainment.inquirer.net
SNSD’s leader and vocalist Taeyeon will release a new EP on June 18, her agency announced.
WU

1
LOOK: Seo Kang-joon’s teaser photos in Bangkok released

2018-06-13 entertainment.inquirer.net
“Are You Human?” star Seo Kang-joon’s teaser photos for a magazine were dropped last Monday, June 11, in various social media sites.
WU

1
Jung So-min to star in remake of hit Japanese series

2018-06-13 entertainment.inquirer.net
“Because This is My First Life” lead actress Jung So-min will be back in the spotlight through the upcoming drama series tentatively titled “100 Million Stars From the Sky” on cable channel tvN.
WU

1
‘Welcome to Waikiki’ stars end real-life relationship

2018-06-13 entertainment.inquirer.net
Lee Yi-kyung and Jung In-sun, stars of “Welcome to Waikiki” have ended their relationship that had lasted more than a year, K-Pop Herald reports.
WU

1
WU / Western Union Co. (The) CURRENT REPORT (Current Report)

2018-06-11 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 8-K ________________________ CURRENT REPORT<
WU

1
WU / Western Union Co. (The) PROSPECTUS FILED PURSUANT TO RULE 424(B)(2) (Prospectus)

2018-06-07 sec.gov
Filed Pursuant to Rule 424(b)(2) Registration File No. 333-213943 CALCULATION OF REGISTRATION FEE
WU

1
Mamamoo’s Hwasa to reveal ‘100% real’ daily life in ‘I Live Alone’

2018-06-07 entertainment.inquirer.net
Hwasa of the South Korean girl group Mamamoo will share her real-life moments on MBC’s variety show, “I Live Alone”.
WU

1
Missing ‘I Am Not A Robot’? Here’s a new Korean series for you

2018-06-07 entertainment.inquirer.net
It was late last year when hit series “I Am Not A Robot” made K-drama enthusiasts fall in love. Stars Yoo Seung-ho and Chae Soo-bin enjoyed the rise of their popularity here in the Philippines, with Filipinos expressing their kilig over the drama on various social media sites.
WU

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to WU / Western Union Co. (The) on message board site Silicon Investor.

VentureLawUSA.com - out for blood..!!!
CUSIP: 959802109